Kane Biotech invention helps grow bone cells

Hey there, time traveller!
This article was published 29/08/2011 (4622 days ago), so information in it may no longer be current.

WINNIPEG — Kane Biotech Inc. has filed for a patent on a new bone tissue regeneration technology.

The new patent covers the invention of a unique combination product using Kane’s competence stimulating peptide (CSP) technology to help grow bone cells by enhancing bone cell binding and bone tissue regeneration.

The Winnipeg company’s entry into this $32-billion global market is in addition to Kane’s primary work in the development and commercialization of products that prevent and remove microbial biofilms,

Kane’s invention has several potential uses, including: repairing dental bone defects such as those caused by bone loss resulting from moderate to severe periodontitis; filling tooth extraction sites or sinus elevation grafting; treatment of fractures; using as a filler in bone; prevention of decrease in the bone substance related to osteoporosis; and prevention of fractures associated with osteoporosis and rheumatoid arthritis.

Kane shares were up one cent in heavy trading this morning to 14.5 cents.

martin.cash@freepress.mb.ca